Clinical trials
Cardiomyopathy, Dilated trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2007 | 2 |
| 2008 | 3 |
| 2011 | 1 |
| 2013 | 2 |
| 2016 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2021 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Terminated | 3 |
| Unknown status | 3 |
| Recruiting | 2 |
| Active, not recruiting | 1 |
| Enrolling by invitation | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| McGill University Health Centre/Research Institute of the McGill University Health Centre | 3 |
| Wayne State University | 2 |
| Affinia Therapeutics | 1 |
| Carelon Research | 1 |
| Duke University | 1 |
| McGill University | 1 |
| Oliver Strohm | 1 |
| Pfizer | 1 |
| St. Boniface Hospital | 1 |
| Tenaya Therapeutics | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cardiomyopathy, Dilated | 16 |
| Cardiomyopathy, Hypertrophic | 4 |
| Cardiomyopathies | 3 |
| Heart Failure | 3 |
| Cardiomyopathy, Restrictive | 2 |
| Mitral Valve Insufficiency | 2 |
| Aortic Valve Insufficiency | 1 |
| Aortic Valve Stenosis | 1 |
| Coronary Artery Disease | 1 |
| Fibrosis | 1 |
Trials
Showing 51 to 16 of 16. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.